COVID-19 pandemic reverses global life expectancy gains, reveals comprehensive study

In a recent study published in The Lancet, a group of researchers examined global demographic trends from 1950 to 2021, focusing on changes in mortality and life expectancy, including the significant impact of the coronavirus disease 2019 (COVID-19) pandemic across 204 countries and 811 subnational locations.

Study: Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Image Credit: Lightspring / ShutterstockStudy: Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Image Credit: Lightspring / Shutterstock

Background 

The COVID-19 pandemic has underscored the importance of understanding demographic trends to inform public health policies and prepare for future challenges. Analyzing mortality, life expectancy, and population growth provides insight into health risks, aids resource allocation, and guides development planning. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 enhances this understanding by incorporating pandemic data, offering a detailed view of global health from 1950 to 2021. Further research is needed to continuously update and refine our understanding of demographic trends and their impacts on global health, particularly in the aftermath of the COVID-19 pandemic and emerging health challenges. 

About the study 

The GBD 2021 iteration updated demographic estimates with the latest data and methods, refining the methodology from GBD 2019 and incorporating the impact of the COVID-19 pandemic. This comprehensive approach involved estimating fertility and mortality rates, adjusting for Human Immunodeficiency Virus (HIV) impacts and pandemic-related excess mortality, and accounting for demographic discontinuities like wars and natural disasters to refine population size estimates. Adhering to the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER), the study used Python, Stata, and R for statistical analysis and drew upon a vast array of data sources.

A significant innovation was the estimation of excess mortality due to COVID-19, defined as the observed versus expected all-cause mortality during 2020 and 2021, capturing both direct and indirect pandemic impacts. The study employed a Bayesian hierarchical model for population estimates, adjusted for new data and pandemic effects, covering 204 countries and territories, including subnational analyses for 21 countries. Through uncertainty analysis involving thousands of data draws, GBD 2021 offers a detailed view of global demographic changes and the profound impact of the COVID-19 pandemic, highlighting the dynamic interplay between health, demographic trends, and major global events.

Study results 

The present study provides comprehensive insights into civil registration and vital statistics, highlighting global, regional, and national trends in demographic metrics, including key findings on the completeness of death registration systems. From 1975 to 2016, global death registration completeness improved significantly, peaking at 61.1% before experiencing a slight decline due to reporting lags. Notably, China and India saw significant advances, with peaks of 71.2% and 80.1% completeness, respectively. However, outside these countries, progress was more modest, especially in sub-Saharan Africa, where peak completeness barely reached 8.7%.

Global and GBD super-region all-cause mortality rates across the lifespan in females (A) and males (B), 1950–2021. Mortality rates are expressed as the number of deaths per 1000 population. Fatal discontinuities are indicated by the following letters:

Global and GBD super-region all-cause mortality rates across the lifespan in females (A) and males (B), 1950–2021. Mortality rates are expressed as the number of deaths per 1000 population. Fatal discontinuities are indicated by the following letters: A=HIV epidemic; B=conflicts in the Middle East; C=war and genocide in India, Pakistan, and Bangladesh in 1971; D=war and genocide in Cambodia in the 1970s; E=Rwandan genocide in 1994; F=earthquake in Haiti in 2010; G=famine between 1959 and 1961. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.

The period from 1950 to 2019 witnessed a substantial decline in global age-standardized all-cause mortality rates, from 1980.5 to 736.1 per 100,000 population, reflecting a 62.8% reduction. Despite the overall improvement, the age group 15–39 years exhibited varying mortality trends due to several mortality shocks, including wars, the HIV epidemic, and natural disasters, with a distinct impact on male mortality rates. The COVID-19 pandemic reversed these declining mortality trends, especially among those aged 15 years and older, highlighting the pandemic's significant impact on global health.

Registration completeness varied significantly across regions, with marked improvements in Asia but slower progress in other areas. The study also detailed how the number of deaths due to all causes increased over time, reflecting population growth and aging. Remarkably, under-5 mortality continued to decline even during the pandemic, underscoring ongoing progress in child health.

Life expectancy trends revealed steady global increases from 1950 to 2019, with life expectancy at birth rising by 22.7 years. However, the pandemic led to a notable decrease in life expectancy across all regions, with varying impacts across different countries and territories. The study estimated 5.89 million and 9.97 million excess deaths globally for 2020 and 2021, respectively, due to the pandemic, with the highest excess mortality rates observed in Bulgaria and Lesotho.

Analyzing life expectancy against the Socio-demographic Index (SDI) showed that higher SDI levels were generally associated with longer life expectancies. However, the COVID-19 pandemic's impact on excess mortality rates highlighted that higher SDI levels did not consistently correlate with lower excess mortality rates, indicating the complex interplay of factors influencing pandemic outcomes across different regions.

Global distribution of age-standardized excess mortality rates due to the COVID-19 pandemic, 2020 and 2021 combined. Mortality rates are expressed as the number of deaths per 100,000 population. Excess mortality rates are negative in countries and territories where fewer deaths occurred than predicted.

Global distribution of age-standardized excess mortality rates due to the COVID-19 pandemic, 2020 and 2021 combined. Mortality rates are expressed as the number of deaths per 100,000 population. Excess mortality rates are negative in countries and territories where fewer deaths occurred than predicted.

The global population continued to grow, reaching 7.89 billion in 2021, with most growth concentrated in sub-Saharan Africa, South Asia, and Southeast Asia. Notably, the age structure of populations globally shifted towards older ages, with significant increases in the proportion of the population aged 65 years and older in many countries. 

Journal reference:
  • Austin E Schumacher, Hmwe Hmwe Kyu, Amirali Aali, et al.Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021, The Lancet (2024), DOI -10.1016/S0140-6736(24)00476-8, https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00476-8/fulltext
Vijay Kumar Malesu

Written by

Vijay Kumar Malesu

Vijay holds a Ph.D. in Biotechnology and possesses a deep passion for microbiology. His academic journey has allowed him to delve deeper into understanding the intricate world of microorganisms. Through his research and studies, he has gained expertise in various aspects of microbiology, which includes microbial genetics, microbial physiology, and microbial ecology. Vijay has six years of scientific research experience at renowned research institutes such as the Indian Council for Agricultural Research and KIIT University. He has worked on diverse projects in microbiology, biopolymers, and drug delivery. His contributions to these areas have provided him with a comprehensive understanding of the subject matter and the ability to tackle complex research challenges.    

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kumar Malesu, Vijay. (2024, March 13). COVID-19 pandemic reverses global life expectancy gains, reveals comprehensive study. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20240313/COVID-19-pandemic-reverses-global-life-expectancy-gains-reveals-comprehensive-study.aspx.

  • MLA

    Kumar Malesu, Vijay. "COVID-19 pandemic reverses global life expectancy gains, reveals comprehensive study". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20240313/COVID-19-pandemic-reverses-global-life-expectancy-gains-reveals-comprehensive-study.aspx>.

  • Chicago

    Kumar Malesu, Vijay. "COVID-19 pandemic reverses global life expectancy gains, reveals comprehensive study". News-Medical. https://www.news-medical.net/news/20240313/COVID-19-pandemic-reverses-global-life-expectancy-gains-reveals-comprehensive-study.aspx. (accessed November 22, 2024).

  • Harvard

    Kumar Malesu, Vijay. 2024. COVID-19 pandemic reverses global life expectancy gains, reveals comprehensive study. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20240313/COVID-19-pandemic-reverses-global-life-expectancy-gains-reveals-comprehensive-study.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Public trust in COVID-19 vaccine science influences vaccine uptake in the US